Woodline Partners’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,012,044
Closed -$10M 929
2025
Q2
$10M Sell
1,012,044
-166,719
-14% -$1.76M 0.05% 435
2025
Q1
$15.3M Buy
1,178,763
+384,288
+48% +$5.09M 0.1% 276
2024
Q4
$10.1M Buy
794,475
+17,156
+2% +$208K 0.07% 339
2024
Q3
$8.66M Sell
777,319
-228,708
-23% -$2.52M 0.07% 324
2024
Q2
$11.3M Sell
1,006,027
-362,740
-27% -$4.22M 0.11% 232
2024
Q1
$17M Buy
1,368,767
+79,075
+6% +$1.03M 0.16% 195
2023
Q4
$18M Buy
1,289,692
+140,390
+12% +$1.95M 0.2% 158
2023
Q3
$17M Sell
1,149,302
-633,096
-36% -$8.9M 0.2% 150
2023
Q2
$23M Buy
1,782,398
+1,716,617
+2,610% +$19.6M 0.27% 107
2023
Q1
$645K Buy
+65,781
New +$702K 0.01% 509
2022
Q4
Sell
-1,476,266
Closed -$15.4M 783
2022
Q3
$15.4M Buy
1,476,266
+389,383
+36% +$5.07M 0.22% 141
2022
Q2
$13.7M Buy
+1,086,883
New +$11.5M 0.21% 146

Other funds holding DVAX

Woodline Partners's DVAX Position: Q3 2025 in Review

Woodline Partners sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 1,012,044 shares — an estimated $10M sold.

Woodline Partners first reported a position in DVAX in Q2 2022 and held it in 12 quarters. The position peaked at $23M in Q2 2023. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Woodline Partners reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Woodline Partners sold 1,012,044 Dynavax Technologies shares in Q3 2025, an estimated $10M.
  • Woodline Partners first reported a position in Dynavax Technologies in Q2 2022 and held it in 12 quarters.
  • Woodline Partners's Dynavax Technologies position peaked at $23M in Q2 2023.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.